Newsroom

Press Release

NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017

NeoGenomics Closes $150 Million Senior Credit Facility

NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016

NeoGenomics Schedules its Q3 2016 Earnings Release for October 26, 2016

NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

NeoGenomics Schedules its Q2 2016 Earnings Release for July 26, 2016

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients